No definition available.
Congenital malformations of ear causing impairment of hearing
Q17_CONGEN_MALFO_EAR_CAUSI_IMPAIRM_HEARING
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
130 |
4. Check minimum number of eventsNone |
130 |
5. Include endpointsNone |
130 |
6. Filter based on genotype QC (FinnGen only) |
130 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae auris cum hypacusi
Similar endpoints
↥List of similar endpoints to
Congenital malformations of ear causing impairment of hearing
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1650 | 742 | 906 |
| Only index persons | 1416 | 646 | 770 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.03 |
| Only index persons | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 11.63 | 13.91 | 9.73 |
| Only index persons | 14.11 | 16.09 | 12.45 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 130 | 75 | 55 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 27.56 | 22.65 | 34.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 120
- Matched controls
- 1201
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
+∞
69.7
60
*
Q17.2
ICD-10 Finland
Microtia
+∞
34.0
31
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
156.4
33.7
34
*
Q16.3
ICD-10 Finland
Congenital malformation of ear ossicles
+∞
30.5
28
*
Q16.0
ICD-10 Finland
Congenital absence of (ear) auricle
+∞
28.2
26
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
45.7
25.8
31
9
UDC00
NOMESCO Finland
Ear microscopy
15.1
25.2
44
44
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
148.5
23.5
24
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
8.7
20.2
49
88
DFF00
NOMESCO Finland
Pure tone audiometry
12.2
19.6
37
42
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
111.9
18.1
19
*
DC1AD
NOMESCO Finland
Temporalbone CT
39.5
16.3
20
6
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
37.2
15.3
19
6
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
8.1
15.1
36
60
DAD10
NOMESCO Finland
Reconstruction of auricle
+∞
13.8
13
*
DBD30
NOMESCO Finland
Correction of atresia of external auditory canal
+∞
13.8
13
*
ZXC10
NOMESCO Finland
Use of laser
42.4
12.5
15
*
DDA00
NOMESCO Finland
Stapedotomy
42.4
12.5
15
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
24.4
12.4
17
8
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
+∞
10.6
10
*
ZXA00
NOMESCO Finland
Right side
4.2
9.8
42
135
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
5.8
9.5
28
60
Q16.4
ICD-10 Finland
Other congenital malformations of middle ear
+∞
9.5
9
*
Q16.9
ICD-10 Finland
Congenital malformation of ear causing impairment of hearing, unspecified
+∞
9.5
9
*
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
30.0
8.6
11
*
DAD30
NOMESCO Finland
Plastic repair of auricle
+∞
8.4
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
3.2
8.4
59
275
DCD10
NOMESCO Finland
Tympanoplasty
85.1
7.5
8
*
Q67.0
ICD-10 Finland
Facial asymmetry
+∞
7.4
7
*
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
7.4
7
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
13.2
7.3
12
10
ZZG00
NOMESCO Finland
Graft of cartilage
73.6
6.5
7
*
DFF15
NOMESCO Finland
Speech audiometry
12.0
6.4
11
10
Q16.2
ICD-10 Finland
Absence of eustachian tube
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
29
112
3.05
5.88
2.1
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
24
112
2.40
3.32
1.5
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
10
5.15
2.09
2.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
19
107
1.91
1.65
3.6
4.0
%
35.4
31.5
0.69
14
68
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
43
2.44
1.65
1.2
2.4
—
—
—
0
0
(3013512) EKG study
33
221
1.66
1.63
3.5
3.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
16
3.21
1.45
1.2
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6
131
0.43
1.38
2.0
5.4
umol/l
3.3
8.4
—
6
109
(3044640) Blood type and Crossmatch panel - Blood
44
328
1.52
1.37
1.9
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
19
2.69
1.22
2.0
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
20
2.56
1.16
1.4
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
21
2.43
1.10
1.2
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
27
190
1.53
1.08
2.8
3.9
ng/l
3351.7
656.6
0.50
22
157
(3003694) ABO and Rh group [Type] in Blood
28
378
0.67
1.06
1.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
31
226
1.49
1.06
4.5
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
183
1.53
1.04
2.1
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
68
1.84
1.04
1.6
6.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
22
2.32
1.04
2.4
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
208
0.58
1.03
1.8
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
54
1.92
0.99
1.0
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
13
77
1.76
0.99
2.8
5.6
mmol/l
1.8
1.8
—
7
55
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
29
0.00
0.99
0.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
28
0.00
0.99
0.0
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
23
318
0.66
0.98
2.9
3.0
e6/l
85.4
28.2
0.69
17
250
(3003338) MCHC [Mass/volume]
92
1004
0.71
0.92
17.2
15.1
g/l
333.3
334.2
0.59
92
998
(3009343) pH of Capillary blood
13
79
1.72
0.92
2.8
5.6
—
7.4
—
0
5
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
29
2.12
0.90
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
18
256
0.66
0.87
4.6
3.8
estimate
0.0
0.0
—
5
99
(3004588) Protein electrophoresis panel - Serum or Plasma
8
45
1.83
0.86
6.5
3.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
19
132
1.51
0.81
2.8
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
24
0.00
0.80
0.0
3.2
—
0.4
—
0
16
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.80
0.0
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
22
159
1.46
0.79
1.6
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
41
333
1.34
0.76
2.0
1.8
pmol/l
95.2
96.5
0.06
19
170
(3001019) Free T4 and TSH panel - Serum or Plasma
10
60
1.72
0.74
1.1
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
93
0.52
0.70
1.0
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
63
551
1.28
0.67
5.3
7.3
e9/l
0.2
0.2
0.79
55
492
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
85
923
0.77
0.67
3.3
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
29
1.75
0.64
1.6
3.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
22
284
0.73
0.63
3.2
2.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
30
367
0.76
0.60
3.0
3.7
e6/l
22.1
41.5
0.60
18
261
(3019225) pH of Specimen
12
81
1.53
0.59
7.8
6.2
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.1
—
3.3
—
0
9
(40761536) Microorganisms panel - Urine sediment
5
86
0.56
0.58
4.6
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
30
242
1.31
0.58
1.8
2.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
120
1155
1.51
0.54
13.3
10.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
40
1.52
0.52
1.3
2.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
40
1.52
0.52
3.3
4.9
%
1.1
1.4
—
6
40
(3021879) Hepatitis B virus core Ab [Presence] in Serum
15
110
1.41
0.51
2.0
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
20
155
1.34
0.50
3.9
2.1
umol/l
12.3
14.7
0.91
20
140
(3030467) Casts [#/volume] in Urine by Automated count
23
285
0.77
0.50
3.2
3.0
e6/l
0.6
0.3
0.48
17
220
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
273
0.77
0.49
2.8
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
12
85
1.45
0.49
1.9
3.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
47
1.52
0.48
2.3
1.8
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
8
117
0.66
0.48
1.4
2.6
nmol/l
447.9
357.9
—
8
107
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
48
1.48
0.47
1.1
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
5
81
0.60
0.47
1.8
2.4
—
26.7
—
0
6
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
99
934
1.25
0.46
9.1
10.2
ml/min/173m2
92.5
92.4
0.01
78
742
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
95
1.41
0.46
4.6
8.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
76
819
0.83
0.45
4.2
3.9
pmol/l
14.4
14.5
0.17
69
756
(3004789) Transferrin [Mass/volume] in Serum or Plasma
18
140
1.33
0.45
4.1
2.1
g/l
2.6
2.4
0.68
18
124
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
78
1.45
0.44
1.9
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6
93
0.63
0.44
7.8
6.4
kpa
5.5
5.2
—
6
87
(3027801) Oxygen [Partial pressure] in Arterial blood
6
93
0.63
0.44
7.8
6.4
kpa
16.4
13.8
—
6
87
(3001122) Ferritin [Mass/volume] in Serum or Plasma
57
512
1.20
0.43
3.2
2.8
ug/l
106.9
86.1
0.20
52
472
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
113
1086
1.31
0.42
14.2
11.9
mg/l
26.9
21.9
0.57
86
798
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
33
1.54
0.42
8.6
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
80
855
0.83
0.42
6.9
4.7
mmol/mol
40.0
38.6
0.65
73
806
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
97
1.38
0.41
1.8
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
60
1.35
0.41
1.5
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
0
18
0.00
0.40
0.0
1.9
—
282.5
—
0
11
(3041096) Erythrocytes [Presence] in Urine by Automated
24
287
0.80
0.40
2.5
2.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
35
1.45
0.39
10.2
5.8
%
79.5
57.3
—
5
35
(3045414) Leukocytes [Presence] in Urine
5
35
1.45
0.39
1.2
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
69
635
1.18
0.39
8.5
10.1
e9/l
4.2
4.1
0.07
61
556
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
19
232
0.79
0.37
1.9
2.4
mg/l
0.4
1.2
1.44
13
168
(3022145) Colonoscopy Study observation
13
99
1.35
0.37
1.2
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
41
1.49
0.36
2.0
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
26
305
0.82
0.36
1.4
1.5
g/l
1.8
2.0
0.25
20
181
(3016502) Oxygen saturation in Arterial blood
5
80
0.61
0.36
9.0
7.1
%
97.3
96.3
—
5
75
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
80
0.61
0.36
1.0
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
35
306
1.20
0.35
4.0
2.9
mmol/l
2.3
2.4
0.18
30
275
(3026782) Osmolality of Urine
16
197
0.79
0.34
2.3
2.6
mosm/kgh2o
526.5
550.2
0.14
16
169
(3020564) Creatinine [Moles/volume] in Serum or Plasma
115
1114
1.28
0.33
13.5
12.6
umol/l
79.0
72.1
0.54
115
1114
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
6
46
1.32
0.33
1.8
2.5
ng/l
100.0
160.3
—
6
38
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
47
1.29
0.32
1.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
47
1.29
0.32
1.7
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
30
342
0.84
0.31
4.5
3.3
u/l
24.5
30.2
1.95
30
320
(3006315) Basophils [#/volume] in Blood
58
534
1.16
0.31
5.5
6.9
e9/l
0.0
0.0
0.16
51
467
(3001604) Monocytes [#/volume] in Blood
58
534
1.16
0.31
5.4
6.9
e9/l
0.6
0.6
0.22
51
465
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
151
0.77
0.30
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
29
330
0.84
0.30
1.3
1.4
u/ml
0.6
1.3
—
8
70
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
57
1.24
0.29
1.4
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
36
321
1.17
0.29
1.5
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
95
988
0.86
0.28
4.0
3.6
mmol/l
1.5
1.5
0.06
90
910
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
72
0.68
0.27
1.4
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
73
0.67
0.27
1.2
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
73
0.67
0.27
1.2
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
33
294
1.16
0.26
1.7
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
46
500
0.88
0.26
8.4
8.8
e9/l
0.0
0.0
0.49
34
401
(3020682) Albumin/Creatinine [Ratio] in Urine
19
222
0.83
0.26
5.4
4.0
mg/mmol
9.9
18.7
0.44
14
131
(3019198) Lymphocytes [#/volume] in Blood
60
560
1.13
0.25
5.5
6.8
e9/l
1.9
1.9
0.30
53
500
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
94
974
0.87
0.23
4.6
4.5
mu/l
1.9
1.8
0.24
84
909
(40768443) Skin Pathology biopsy report
5
38
1.33
0.23
1.6
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
31
344
0.87
0.23
2.7
3.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
18
209
0.84
0.23
1.3
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
91
944
0.88
0.23
3.7
3.4
mmol/l
1.4
1.3
0.45
86
864
(3027008) Opiates [Presence] in Urine
13
107
1.24
0.22
1.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
46
495
0.89
0.21
4.3
4.9
estimate
0.0
0.0
—
5
103
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
163.2
—
0
11
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
5.3
—
1.0
—
0
11
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
5.3
—
115.2
—
0
10
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
1.6
—
0
10
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
20.1
—
0
10
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
15.2
—
0
10
(4198724)
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
2.4
—
0
10
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
97
1001
0.88
0.21
4.4
4.0
mmol/l
2.8
2.8
0.34
91
924
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
15
176
0.83
0.21
2.7
2.9
e6/l
0.9
0.8
—
7
101
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
13
108
1.23
0.21
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
13
108
1.23
0.21
1.8
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
35
382
0.89
0.20
2.1
2.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
14
0.00
0.20
0.0
4.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
14
0.00
0.20
0.0
2.4
—
57.2
—
0
14
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
156
1.18
0.20
2.1
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
247
0.87
0.19
2.5
2.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
13
153
0.83
0.19
22.2
7.5
mmol/l
1.1
1.1
0.02
13
142
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
47
502
0.90
0.19
4.8
6.6
umol/l
9.9
11.8
0.98
40
469
(3013826) Glucose [Moles/volume] in Serum or Plasma
63
598
1.10
0.18
5.4
4.6
mmol/l
7.1
6.5
0.71
55
532
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
163
0.84
0.18
2.3
3.1
e6/l
1.8
2.5
—
6
88
(3025941) Bacteria identified in Stool by Culture
7
62
1.14
0.17
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
47
500
0.91
0.17
3.1
3.5
estimate
0.0
0.0
—
5
96
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
65
0.76
0.17
2.4
3.3
pmol/l
4.3
4.9
—
5
57
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
67
0.74
0.17
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
76
0.78
0.16
1.2
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
6
78
0.76
0.16
1.0
4.5
ug/l
1.8
13.2
—
6
59
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
78
1.17
0.16
3.1
9.1
mmol/l
24.1
24.9
—
9
78
(42870588) Differential panel, method unspecified - Blood
38
354
1.10
0.15
5.1
6.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
128
0.85
0.14
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
68
706
0.92
0.14
4.1
3.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
35
373
0.92
0.13
3.4
3.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
70
676
1.08
0.12
3.8
4.0
—
63.2
—
0
12
(3012095) Magnesium [Moles/volume] in Serum or Plasma
15
167
0.88
0.11
2.7
5.3
mmol/l
0.8
0.8
0.11
15
154
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
86
1.18
0.11
1.4
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
65
628
1.07
0.11
3.1
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
27
289
0.92
0.10
5.0
7.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
14
125
1.13
0.10
3.9
2.6
ug/l
0.8
0.7
—
9
78
(21494755) Public health laboratory ask at order entry panel
15
135
1.13
0.10
1.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
47
489
0.94
0.09
3.1
3.5
estimate
0.0
0.0
—
5
100
(3000764) Benzodiazepines [Presence] in Urine
12
107
1.13
0.09
1.8
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
246
0.92
0.09
1.5
1.7
—
—
—
0
0
(4010399)
7
67
1.05
0.08
2.1
1.4
—
—
—
0
0
(4035726)
6
74
0.80
0.08
1.2
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
27
255
1.07
0.07
3.8
4.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
33
346
0.94
0.07
7.7
6.0
inr
1.6
1.1
—
8
101
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
7
84
0.82
0.07
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
84
0.82
0.07
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
84
0.82
0.07
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
84
0.82
0.07
1.4
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
84
1.08
0.07
1.3
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
94
0.84
0.07
1.4
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
178
1.08
0.06
3.6
4.1
%
20.1
23.3
—
9
76
(3012544) pH of Venous blood
11
100
1.11
0.05
6.3
7.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
42
433
0.96
0.05
11.7
7.9
mmol/l
1.2
1.2
0.31
37
377
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
32
308
1.05
0.05
4.5
3.7
ng/l
23.4
44.1
0.77
18
187
(3000991) Gas panel - Venous blood
10
91
1.11
0.04
8.2
10.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
28
290
0.96
0.03
3.6
3.5
mmol/l
7.8
8.2
0.21
23
247
(3012516) Albumin [Mass/volume] in Urine
20
209
0.95
0.03
6.8
3.3
mg/l
5578.3
125.2
0.77
14
131
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
118
0.93
0.03
1.5
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
371
1.03
0.02
2.2
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
23
223
1.04
0.01
3.4
3.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
10
94
1.07
0.01
18.7
17.3
—
1.2
—
0
17
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
104
1.06
0.01
1.8
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
108
1074
1.03
0.00
13.3
12.4
%
40.6
40.7
0.05
80
878
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
26
266
0.97
0.00
2.0
2.6
mg/l
2.8
2.7
0.14
21
230
(3002256) Pathology report gross observation
12
116
1.04
0.00
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
126
1.04
0.00
1.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
18
176
1.03
0.00
1.4
1.3
iu/ml
18.1
22.6
0.19
11
57
(40768797) Stomach Pathology biopsy report
12
119
1.01
0.00
1.3
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
27
271
1.00
0.00
2.9
2.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
37
368
1.01
0.00
1.8
1.9
—
—
—
0
0
(3015736) pH of Urine
39
388
1.01
0.00
3.2
3.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
48
482
0.99
0.00
4.0
4.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
177
1.02
0.00
1.3
1.2
u/ml
1.0
7.1
—
7
64
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
96
965
0.98
0.00
3.9
3.5
mmol/l
6.0
5.7
0.61
87
886
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
135
1.04
0.00
2.3
2.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
17
165
1.03
0.00
2.9
3.2
ng/l
275.5
218.6
—
8
105
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
105
1.05
0.00
2.2
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
75
754
0.99
0.00
3.1
4.1
mm/h
9.1
10.0
0.30
69
696
(3011288) Drugs identified in Urine by Screen method
7
73
0.96
0.00
2.7
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
7.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
463.0
—
0
5
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
53
0.94
0.00
2.8
1.4
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
0
8
0.00
0.00
0.0
56.1
—
145.1
—
0
8
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
5.8
—
0
6
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
4.3
—
0
5
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1961.3
—
0
8
(3038026) Centromere Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
5.5
—
0
5
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
10.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
25.1
—
0
7
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1540.2
—
0
5
(3000492) Spirometry study
11
110
1.00
0.00
1.0
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
98
0.91
0.00
1.2
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
9.2
—
0
6
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
59
0.84
0.00
1.4
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
17.8
—
10.2
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_EAR_CAUSI_IMPAIRM_HEARING and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_EAR_CAUSI_IMPAIRM_HEARING.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_EAR_CAUSI_IMPAIRM_HEARING – Congenital malformations of ear causing impairment of hearing
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data